Dr. Jeffrey Gonzalez's research focuses on identifying factors associated with treatment nonadherence in and developing interventions to improve treatment adherence among patients with chronic illness, particularly diabetes and HIV/AIDS. His research has recently focused on the link between depression and distress and diabetes treatment nonaderence as a potential pathway for understanding the negative effects of depression on diabetes outcomes.
Dr. Gonzalez has published data showing that symptoms of depression are associated with worse diabetes self-care, even at levels of depressive symptom severity that fall below clinical levels. He recently published a meta-analysis of 47 independent samples showing that the relationship between symptoms of depression and diabetes treatment nonadherence is consistent across patients with type 1 or type 2 diabetes and across a full range of self-care behaviors.
Before coming to Einstein, Dr. Gonzalez was Co-PI of an NIMH-funded R01 to test the efficacy of a cognitive behavioral therapy intervention to improve treatment adherence and treat depression among type 2 patients with clinical depression. He remains involved in this ongoing trial and is currently conducting pilot work to adapt this approach for type 1 and type 2 patients who have distress that does not meet diagnostic thresholds for clinical depression.
Dr. Gonzalez collaborates on an NIDDK-funded trial examining the efficacy of a telephone-delivered intervention to improve treatment adherence in type 2 diabetes patients from the South Bronx with Dr. Elizabeth Walker. He also maintains an ongoing collaboration on a series of studies that have examined predictors of foot care, depression, and quality of life in patients with diabetic peripheral neuropathy.
Material in this section is provided by individual faculty members who are solely responsible for its accuracy and content.